The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)

  Рет қаралды 2,818

OncBrothers: Practice-Changing Cancer Discussions

OncBrothers: Practice-Changing Cancer Discussions

Күн бұрын

Пікірлер: 3
@raulbitran
@raulbitran 20 күн бұрын
you guys just keep making it better and better! please bring back the images, treating schema and screenshots of the main trials
@learnoncologytogether
@learnoncologytogether 21 күн бұрын
excellent summation. thanks.
@bestcookingmethod
@bestcookingmethod 22 күн бұрын
Nice topic
Unpacking the Treatment Algorithm of Hepatocellular Carcinoma with Dr. Tanios S. Bekaii-saab
25:11
Unpacking the Treatment Algorithm of Hepatocellular Carcinoma with Dr. Tanios S. Bekaii-saab
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,3 М.
Exploring the Latest in Renal Cell Cancer Therapies with Dr. Monty Pal using an Algorithm
18:50
Exploring the Latest in Renal Cell Cancer Therapies with Dr. Monty Pal using an Algorithm
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,7 М.
Этот бой - Самое большое РАЗОЧАРОВАНИЕ за всю КАРЬЕРУ БУАКАВА!
01:00
Этот бой - Самое большое РАЗОЧАРОВАНИЕ за всю КАРЬЕРУ БУАКАВА!
БЕЗУМНЫЙ СПОРТ
Рет қаралды 2 МЛН
Quando eu quero Sushi (sem desperdiçar) 🍣
00:26
Quando eu quero Sushi (sem desperdiçar) 🍣
Los Wagners
Рет қаралды 15 МЛН
Мен атып көрмегенмін ! | Qalam | 5 серия
25:41
Мен атып көрмегенмін ! | Qalam | 5 серия
kak budto
Рет қаралды 1,2 МЛН
小丑女COCO的审判。#天使 #小丑 #超人不会飞
00:53
小丑女COCO的审判。#天使 #小丑 #超人不会飞
超人不会飞
Рет қаралды 16 МЛН
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
19:14
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,3 М.
Emerging Evidence on Immunotherapy for HCC Management in Intermediate Stages
59:48
Emerging Evidence on Immunotherapy for HCC Management in Intermediate Stages
The France Foundation
Рет қаралды 55
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
23:35
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
ASCO Podcasts
Рет қаралды 1
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
23:25
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,5 М.
The Cancer Expert: "This Common Food Is Making Cancer Worse!"
1:37:34
The Cancer Expert: "This Common Food Is Making Cancer Worse!"
The Diary Of A CEO
Рет қаралды 6 МЛН
How to Approach to Ovarian Cancer from Community Oncology Perspective
20:14
How to Approach to Ovarian Cancer from Community Oncology Perspective
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 3 М.
NEW Breakthrough for Fatty Liver Recovery in Just 3 Days! | Barbara O'Neill
20:24
NEW Breakthrough for Fatty Liver Recovery in Just 3 Days! | Barbara O'Neill
Eternal Health
Рет қаралды 1,8 МЛН
Breaking The Silence: Sharing My Lung Cancer Diagnosis With You
1:16:33
Breaking The Silence: Sharing My Lung Cancer Diagnosis With You
CHEF AJ
Рет қаралды 137 М.
2nd line treatment in advanced HCC and when to switch
26:19
2nd line treatment in advanced HCC and when to switch
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,5 М.
How to Approach and Treat Pancreatic Cancer
22:28
How to Approach and Treat Pancreatic Cancer
OncBrothers: Practice-Changing Cancer Discussions
Рет қаралды 2,7 М.
Этот бой - Самое большое РАЗОЧАРОВАНИЕ за всю КАРЬЕРУ БУАКАВА!
01:00
Этот бой - Самое большое РАЗОЧАРОВАНИЕ за всю КАРЬЕРУ БУАКАВА!
БЕЗУМНЫЙ СПОРТ
Рет қаралды 2 МЛН